Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05606965 · ClinicalTrials.gov registry record · Phase 2
A Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of mRNA-1010 in Healthy Adults
A Phase 2 study, sponsored by ModernaTX.
- Completed
- Registry status
- Phase 2
- Development phase
- 172
- Enrollment target
NCT05606965: Completed Phase 2 study, sponsored by ModernaTX.
NCT05606965 is a Phase 2 study that has completed, run by ModernaTX. The registered enrollment target is 172 participants, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (29% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05606965, a Phase 2 study, has completed, sponsored by ModernaTX.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 172 participants
- Enrollment target
Study Summary
The main purpose of the study is to evaluate the safety, reactogenicity, and the humoral immunogenicity of mRNA-1010 and comparator influenza vaccines against homologous influenza A and B strains at Day 29.
Interventions
- BIOLOGICAL Inactivated Influenza Vaccine
- BIOLOGICAL mRNA-1345
- BIOLOGICAL mRNA-1010
- BIOLOGICAL Egg-based Quadrivalent Influenza Vaccine
- BIOLOGICAL Adjuvanted Quadrivalent Influenza Vaccine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 172 participants |
| Start Date | 2022-11-02 |
| Est. Completion | 2025-11-13 |
| Phase | Phase 2 |
What the finished NCT05606965 record still lists
NCT05606965 is an interventional study that assigns participants to a tested intervention. The registered 172 participants enrollment target is mid-sized for trials with a published cap, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (29% higher).
The record links to 0 conditions, and to 5 interventions - of which Inactivated Influenza Vaccine is the first listed.
NCT05606965 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05606965 about?
NCT05606965 is a clinical study titled "A Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of mRNA-1010 in Healthy Adults". The main purpose of the study is to evaluate the safety, reactogenicity, and the humoral immunogenicity of mRNA-1010 and comparator influenza vaccines against homologous influenza A and B strains at Day 29.
What is the current status of trial NCT05606965?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 172 participants. The study started on 2022-11-02. Estimated completion is 2025-11-13.
What interventions are being tested in trial NCT05606965?
The interventions under investigation include: Inactivated Influenza Vaccine (BIOLOGICAL), mRNA-1345 (BIOLOGICAL), mRNA-1010 (BIOLOGICAL), Egg-based Quadrivalent Influenza Vaccine (BIOLOGICAL), Adjuvanted Quadrivalent Influenza Vaccine (BIOLOGICAL).
Who is sponsoring clinical trial NCT05606965?
This trial is sponsored by ModernaTX, which has 90 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05606965's enrollment target sits among peer trials
172 397th of 2000 higher than 1,603 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04801797 · 172 participants · Phase 2
Venetoclax + Azacitidine vs. Induction Chemotherapy in AML
- NCT04867317 · 172 participants · Phase 3
Growth Hormone Replacement Therapy in Veterans With Mild Traumatic Brain Injury (mTBI) and Adult Growth Hormone Deficiency (AGHD)
- NCT05357040 · 172 participants · Phase 2
Antidepressant Effects of Nitrous Oxide
- NCT05587517 · 172 participants · Phase 2
A Clinical Trial of Interventions to Support Family Surrogates of Critically Ill Patients
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI